DK105824C - Fremgangsmåde til fremstilling af en vandopløselig tilberedningsform af 3,5-dinitro-o-toluamid. - Google Patents

Fremgangsmåde til fremstilling af en vandopløselig tilberedningsform af 3,5-dinitro-o-toluamid.

Info

Publication number
DK105824C
DK105824C DK161265A DK161265A DK105824C DK 105824 C DK105824 C DK 105824C DK 161265 A DK161265 A DK 161265A DK 161265 A DK161265 A DK 161265A DK 105824 C DK105824 C DK 105824C
Authority
DK
Denmark
Prior art keywords
toluamide
dinitro
preparation
water
dosage form
Prior art date
Application number
DK161265A
Other languages
English (en)
Original Assignee
Boehringer & Soehne Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer & Soehne Gmbh filed Critical Boehringer & Soehne Gmbh
Application granted granted Critical
Publication of DK105824C publication Critical patent/DK105824C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
DK161265A 1964-05-02 1965-03-27 Fremgangsmåde til fremstilling af en vandopløselig tilberedningsform af 3,5-dinitro-o-toluamid. DK105824C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB76617A DE1209700B (de) 1964-05-02 1964-05-02 Verfahren zur Herstellung einer wasserloeslichen Zubereitungsform des 3, 5-Dinitro-o-toluamids

Publications (1)

Publication Number Publication Date
DK105824C true DK105824C (da) 1966-11-14

Family

ID=6979159

Family Applications (1)

Application Number Title Priority Date Filing Date
DK161265A DK105824C (da) 1964-05-02 1965-03-27 Fremgangsmåde til fremstilling af en vandopløselig tilberedningsform af 3,5-dinitro-o-toluamid.

Country Status (9)

Country Link
AT (1) AT261293B (da)
BE (1) BE663315A (da)
DE (1) DE1209700B (da)
DK (1) DK105824C (da)
GB (1) GB1032406A (da)
IL (1) IL23427A (da)
LU (1) LU48505A1 (da)
NL (1) NL6505533A (da)
SE (1) SE303569B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL184257C (nl) * 1974-06-19 1989-06-01 Merck & Co Inc Werkwijze voor het bereiden van rafoxanide preparaten.
BR0213235A (pt) * 2002-09-13 2004-09-28 New Pharma Res Sweden Ab Composição e método de potenciação

Also Published As

Publication number Publication date
DE1209700B (de) 1966-01-27
IL23427A (en) 1968-08-22
SE303569B (da) 1968-09-02
NL6505533A (da) 1965-11-03
BE663315A (da) 1965-11-03
LU48505A1 (da) 1965-06-29
AT261293B (de) 1968-04-10
GB1032406A (en) 1966-06-08

Similar Documents

Publication Publication Date Title
DK125553B (da) Fremgangsmåde til fremstilling af substituerede 2,4-diamino-5-benzylpyrimidiner.
DK120546B (da) Fremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimidiner.
DK116441B (da) Fremgangsmåde til fremstilling af 10,11-dihydro-dibenzo-(b,f)-thiepinderivater.
DK112523B (da) Fremgangsmåde til fremstilling af 2,3-pyridindiol.
DK129126B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepiner.
DK120752B (da) Fremgangsmåde til fremstilling af 5-aryl-3H-1,4-benzodiazepin-4-oxider.
DK108921C (da) Fremgangsmåde til fremstilling af tetrahydro-1,3,5-thiadiazin-2-thioner.
DK112033B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkyl-17β-hydroxy-17α-ethinylgona-5(10),9(11)-diener.
DK114273B (da) Fremgangsmåde til fremstilling af α-methyl-α-amino-β-(3,4-disubstituerede-phenyl)-propionitriler.
DK105824C (da) Fremgangsmåde til fremstilling af en vandopløselig tilberedningsform af 3,5-dinitro-o-toluamid.
DK115184B (da) Fremgangsmåde til fremstilling af 6,7-benzomorphaner.
DK131903B (da) Fremgangsmåde til fremstilling af L-(-)-beta-(3,4-dihydroxyphenyl)-alfa-methylalanin.
DK120347B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepin-4-oxider.
DK116357B (da) Fremgangsmåde til fremstilling af 1,1,1,2,2-pentafluor-3-chlorpropan.
DK112031B (da) Fremgangsmåde til fremstilling af 3,20-dioxo-17α-methyl-19-nor-pregna-4,9,11-trien.
DK116594B (da) Fremgangsmåde til fremstilling af 4,1,5-benzoxadiazociner.
DK114962B (da) Fremgangsmåde til fremstilling af α, α, α&#39;, α&#39;-tetramethyl-xylylen-dicarbinoler.
DK126936B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener.
DK115622B (da) Fremgangsmåde til fremstilling af 3-oxogona-4,9,11-triener.
DK120131B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener.
DK113917B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetrachlorcyclohexanon.
DK117956B (da) Fremgangsmåde til fremstilling af 3-oxogona-4,9-diener.
DK114204B (da) Fremgangsmåde til fremstilling af carboxamidoalkyl-1,3-benzoxaziner.
DK109639C (da) Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy-17α-methylestra-4,9,11-trien.
DK118947B (da) Fremgangsmåde til fremstilling af 1,2-dihydro-4-hydroxyquinazolin-3-oxider.